We are live on ! Find out more
ROSG

Rosetta Genomics Ltd.
ROSG

Delisted

ROSG was delisted on the 21st of May, 2018.

Back to rankings

12 hedge funds and large institutions have $1.16M invested in Rosetta Genomics Ltd. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

31% more capital invested

Capital invested by funds: $887K → $1.16M (+$277K)

25% less funds holding

Funds holding: 16 → 12 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$167K
2
HCM
Highlander Capital Management
New Jersey
+$122K
3
Millennium Management
Millennium Management
New York
+$114K
4
VKH
Virtu KCG Holdings
New York
+$73.9K
5
TRCT
Tower Research Capital (TRC)
New York
+$28.7K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$194K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$66K
3
ARTA
A.R.T. Advisors
New York
-$37K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$34K
5
Goldman Sachs
Goldman Sachs
New York
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$495K +$122K +3,229 +31%
Morgan Stanley
2
Morgan Stanley
New York
$188K +$167K +4,410 +678%
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$147K – – –
Millennium Management
4
Millennium Management
New York
$111K +$114K +3,001 New
VKH
5
Virtu KCG Holdings
New York
$72K +$73.9K +1,951 New
SIM
6
Spark Investment Management
New York
$70K -$947 -25 -1%
TRCT
7
Tower Research Capital (TRC)
New York
$35K +$28.7K +758 +401%
Group One Trading
8
Group One Trading
Illinois
$20K +$10.2K +268 +97%
Creative Planning
9
Creative Planning
Kansas
$15K +$15.8K +417 New
Wells Fargo
10
Wells Fargo
California
$6K -$5K -132 -44%
Citigroup
11
Citigroup
New York
$4K +$568 +15 +18%
AIG
12
American International Group
New York
$1.85K -$1.48K -39 -44%
AFM
13
Anson Funds Management
Texas
– -$194K -7,168 Closed
SKK
14
Shepherd Kaplan Krochuk
Massachusetts
– -$66K -2,431 Closed
ARTA
15
A.R.T. Advisors
New York
– -$37K -1,374 Closed
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
– -$34K -1,255 Closed
Goldman Sachs
17
Goldman Sachs
New York
– -$29K -1,051 Closed
UBS Group
18
UBS Group
Switzerland
– -$7K -271 Closed

ROSG Hedge Fund Activity: Q1 2015 in Review

12 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q1 2015, worth a combined $1.16M — up 31% from $887K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ROSG and 3 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 5 added.

The largest buyer was Morgan Stanley, adding an estimated $167K. The largest seller was Anson Funds Management, exiting entirely with an estimated $194K sold.

  • 12 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q1 2015, down from 16 in Q4 2014.
  • Funds reported $1.16M of Rosetta Genomics Ltd. stock for Q1 2015, up 31% quarter-over-quarter.
  • 3 funds opened new Rosetta Genomics Ltd. positions in Q1 2015 and 7 closed out, a net change of -4 holders.
  • The largest Rosetta Genomics Ltd. buyer in Q1 2015 was Morgan Stanley, an estimated $167K added.
  • The largest Rosetta Genomics Ltd. seller in Q1 2015 was Anson Funds Management, an estimated $194K sold.

Based on aggregated 13F filings for Q1 2015.